|
参考文献： [1] American Diabetes Association. 14. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes-2020. Diabetes care. 2020 Jan;43(Suppl 1):S183-S192. doi: 10.2337/dc20-S014. [2] Britton LE, Hussey JM, Berry DC, et al. Contraceptive use among women with prediabetes and diabetes in a US national sample. J Midwifery Womens Health. 2019;64(1):36–45. doi: 10.1111/jmwh.12936. [3] Morris JR, Tepper NK. Description and comparison of postpartum use of effective contraception among women with and without diabetes. Contraception. 2019,100(6):474-479. doi: 10.1016/j.contraception.2019.08.008. [4] Wu JP, Moniz MH, Ursu AN. Long-acting reversible contraception-highly efficacious, safe, and underutilized. JAMA. 2018;320(4):397–398. doi: 10.1001/jama.2018.8877. [5] ACOG Practice Bulletin No. 201: Pregestational Diabetes Mellitus. Obstet Gynecol 2018; 132(6):e228–e248. doi: 10.1097/AOG.0000000000002960. [6] ACOG Committee Opinion No. 762: Prepregnancy Counseling. Obstet Gynecol 2019;133(1): e78–e89. doi: 10.1097/AOG.0000000000003013. [7] Alexander EK, Pearce EN, Brent GA, et al. 2017 guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid 2017;27(3):315–389. doi: 10.1089/thy.2016.0457. [8] ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus. Obstet Gynecol 2018;131(2): e49–e64. doi: 10.1097/AOG.0000000000002501. [9] Ho Y-R, Wang P, Lu M-C, et al. Associations of mid-pregnancy HbA1c with gestational diabetes and risk of adverse pregnancy outcomes in high-risk Taiwanese women. PLoS One. 2017;12(5):e0177563. doi: 10.1371/journal.pone.0177563. [10] Metzger BE, Lowe LP, Dyer AR, et al.; HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991–2002. doi: 10.1056/NEJMoa0707943. [11] Feig DS, Donovan LE, Corcoy R, et al.; CONCEPTT Collaborative Group. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomized controlled trial. Lancet 2017;390(10110):2347–2359. doi: 10.1016/S0140-6736(17)32400-5. [12] Kristensen K, Ogge LE, Sengpiel V, et al. Continuous glucose monitoring in pregnant women with type 1 diabetes: an observational cohort study of 186 pregnancies. Diabetologia. 2019;62(7):1143–1153. doi: 10.1007/s00125-019-4850-0. [13] Law GR, Gilthorpe MS, Secher AL, et al. Translating HbA1c measurements into estimated average glucose values in pregnant women with diabetes. Diabetologia. 2017;60(4):618–624. doi: 10.1007/s00125-017-4205-7. [14] Wang C, Wei Y, Zhang X, et al. A randomized clinical trial of exercise during pregnancy to prevent gestational diabetes mellitus and improve pregnancy outcome in overweight and obese pregnant women. Am J Obstet Gynecol. 2017;216(4):340–351. doi: 10.1016/j.ajog.2017.01.037. [15] Institute of Medicine and National Research Council. Weight Gain During Pregnancy: Reexamining the Guidelines. Washington, D.C., National Academies Press, 2009. [16] Farrar D, Tuffnell DJ, West J, et al. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes. Cochrane Database Syst Rev. 2016;6:CD005542. doi: 10.1002/14651858.CD005542. [17] Hebert MF, Ma X, Naraharisetti SB, et al.;Obstetric-Fetal Pharmacology Research Unit Network. Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice. Clin Pharmacol Ther. 2009;85(6):607–614. doi: 10.1038/clpt.2009.5. [18] Malek R, Davis SN. Pharmacokinetics, efficacy and safety of glyburide for treatment of gestational diabetes mellitus. Expert Opin Drug Metab Toxicol. 2016;12(6):691–699. doi: 10.1080/17425255.2016.1187131. [19] Rowan JA, Rush EC, Plank LD, et al. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7-9 years of age. BMJ Open Diabetes Res Care. 2018;6(1):e000456. doi: 10.1136/bmjdrc-2017-000456. [20] Hanem LGE, Stridsklev S, Julıusson PB, et al. Metformin use in PCOS pregnancies increases the risk of offspring overweight at 4 years of age: follow-up of two RCTs. J Clin Endocrinol Metab. 2018;103(4):1612–1621. doi: 10.1210/jc.2017-02419. [21] Tarry-Adkins JL, Aiken CE, Ozanne SE. Neonatal, infant, and childhood growth following metformin versus insulin treatment for gestational diabetes: a systematic review and meta-analysis. PLoS Med. 2019;16(8):e1002848. doi: 10.1371/journal.pmed. [22] Barbour LA, Feig DS. Metformin for gestational diabetes mellitus: progeny, perspective, and a personalized approach. Diabetes Care. 2019;42(3):396–399. doi: 10.2337/dci18-0055 [23] Barbour LA, Scifres C, Valent AM, et al. A cautionary response to SMFM statement: pharmacological treatment of gestational diabetes. Am J Obstet Gynecol. 2018;219(4):367.e1–367.e7. doi: 10.1016/j.ajog.2018.06.013. [24] Vanky E, Stridsklev S, Heimstad R, et al. Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study. J Clin Endocrinol Metab. 2010;95(12):E448–E455. doi: 10.1210/jc.2010-0853. [25] Feig DS, Corcoy R, Donovan LE, et al.; CONCEPTT Collaborative Group. Pumps or multiple daily injections in pregnancy involving type 1 diabetes: a prespecified analysis of the CONCEPTT randomized trial. Diabetes Care. 2018;41(12):2471–2479. doi: 10.2337/dc18-1437 [26] International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. 2018;72(1):24–43. doi: 10.1161/HYPERTENSIONAHA.117.10803. [27] ACOG Practice Bulletin No. 203: Chronic Hypertension in Pregnancy. Obstet Gynecol. 2019;133(1):e26–e50. doi: 10.1097/AOG.0000000000003020. |
|
|
